Rankings
▼
Calendar
INDV Q2 2023 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q2 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$276M
+24.9% YoY
Gross Profit
$226M
81.9% margin
Operating Income
$61M
22.1% margin
Net Income
$39M
14.1% margin
EPS (Diluted)
$0.28
QoQ Revenue Growth
+9.1%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.6B
Stockholders' Equity
$117M
Cash & Equivalents
$592M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$276M
$221M
+24.9%
Gross Profit
$226M
$183M
+23.5%
Operating Income
$61M
$63M
-3.2%
Net Income
$39M
$48M
-18.8%
← FY 2023
All Quarters
Q3 2023 →